Your browser doesn't support javascript.
loading
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
Nazha, Aziz; Hu, Zhen-Huan; Wang, Tao; Lindsley, R Coleman; Abdel-Azim, Hisham; Aljurf, Mahmoud; Bacher, Ulrike; Bashey, Asad; Cahn, Jean-Yves; Cerny, Jan; Copelan, Edward; DeFilipp, Zachariah; Diaz, Miguel Angel; Farhadfar, Nosha; Gadalla, Shahinaz M; Gale, Robert Peter; George, Biju; Gergis, Usama; Grunwald, Michael R; Hamilton, Betty; Hashmi, Shahrukh; Hildebrandt, Gerhard C; Inamoto, Yoshihiro; Kalaycio, Matt; Kamble, Rammurti T; Kharfan-Dabaja, Mohamed A; Lazarus, Hillard M; Liesveld, Jane L; Litzow, Mark R; Majhail, Navneet S; Murthy, Hemant S; Nathan, Sunita; Nishihori, Taiga; Pawarode, Attaphol; Rizzieri, David; Sabloff, Mitchell; Savani, Bipin N; Schachter, Levanto; Schouten, Harry C; Seo, Sachiko; Shah, Nirav N; Solh, Melhem; Valcárcel, David; Vij, Ravi; Warlick, Erica; Wirk, Baldeep; Wood, William A; Yared, Jean A; Alyea, Edwin; Popat, Uday.
Afiliação
  • Nazha A; Cleveland Clinic, Cleveland, Ohio. Electronic address: nazhaa@ccf.org.
  • Hu ZH; Department of Medicine, CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Wang T; Department of Medicine, CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Lindsley RC; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Abdel-Azim H; Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California.
  • Aljurf M; Department of Oncology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Bacher U; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Bashey A; Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia.
  • Cahn JY; Department of Hematology, CHU Grenoble Alpes, Grenoble, France.
  • Cerny J; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, Masschusetts.
  • Copelan E; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • DeFilipp Z; Blood and Marrow Transplantation Program, Massachusetts General Hospital, Boston, Massachusetts.
  • Diaz MA; Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.
  • Farhadfar N; Division of Hematology/Oncology, University Florida College of Medicine, Gainesville, Florida.
  • Gadalla SM; Division of Cancer Epidemiology & Genetics, NIH-NCI Clinical Genetics Branch, Rockville, Maryland.
  • Gale RP; Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom.
  • George B; Christian Medical College, Vellore, India.
  • Gergis U; Hematologic Malignancies & Bone Marrow Transplant, Department of Medical Oncology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York.
  • Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Hamilton B; Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Hashmi S; Department of Oncology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia; Department of Internal Medicine, Mayo Clinic, Minnesota, Rochester.
  • Hildebrandt GC; Markey Cancer Center, University of Kentucky, Lexington, Kentucky.
  • Inamoto Y; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Kalaycio M; Cleveland Clinic, Cleveland, Ohio.
  • Kamble RT; Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
  • Kharfan-Dabaja MA; Divison of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
  • Lazarus HM; Case Western Reserve University, Cleveland, Ohio.
  • Liesveld JL; Department of Medicine, University of Rochester Medical Center, Rochester, New York.
  • Litzow MR; Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, Minnesota.
  • Majhail NS; Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Murthy HS; Divison of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
  • Nathan S; Rush University Medical Center, Chicago, Illinois.
  • Nishihori T; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, Florida.
  • Pawarode A; Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
  • Rizzieri D; Divison of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina.
  • Sabloff M; Division of Hematology, Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Schachter L; Oregon Health and Science University, Portland, Oregon.
  • Schouten HC; Department of Hematology, Academische Ziekenhuis, Maastricht, Netherlands.
  • Seo S; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
  • Shah NN; Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Solh M; The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, Georgia.
  • Valcárcel D; Department of Hematology, Hospital Vall d'Hebron, Barcelona, Spain.
  • Vij R; Division of Hematology and Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Warlick E; University of Minnesota Blood and Marrow Transplant Program, Minneapolis, Minnesota.
  • Wirk B; Penn State Cancer Institute, Bone Marrow Transplant Program, Hershey, Pennsylvania.
  • Wood WA; Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina.
  • Yared JA; Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, Maryland.
  • Alyea E; Center of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Popat U; Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
Biol Blood Marrow Transplant ; 26(11): 2139-2146, 2020 11.
Article em En | MEDLINE | ID: mdl-32781289
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article